Oral phenobarbital and imepitoin in particular, followed by potassium bromide and levetiracetam are likely to be effective for the treatment of canine idiopathic epilepsy. There is strong evidence supporting the use of oral phenobarbital and imepitoin as ‘first line’ medications. However, there remains a lack of evidence for targeted treatment for the various individual epileptic phenotypes and quite limited evidence on direct comparisons of the efficacy between various anti-epileptic drugs
Background: The safety profile of anti-epileptic drugs (AEDs) is an important consideration for the ...
A significant number of cases of clinical canine epilepsy remain difficult to control in spite of th...
Eleven dogs diagnosed with refractory idiopathic epilepsy were treated orally with gabapentin for a ...
Abstract Background Imepitoin ...
Background: Various antiepileptic drugs (AEDs) are used for the management of canine idiopathic epil...
The purpose of this study was to evaluate the long-term (12 months) efficacy and tolerability of ime...
Background: Epilepsy is a chronic neurological condition characterised by recurrent epileptic seizur...
A one-year clinical trial was conducted to compare phenobarbital and potassium bromide (KBr) monothe...
Idiopathic Epilepsy (IE) in the dog is the major cause of epileptic seizures. Neoplasia, inflammator...
Abstract Background Behavioural changes associated with idiopathic epilepsy (IE) have been identifie...
In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over th...
In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over th...
Epilepsy is a common neurological disorder affecting 0.6–0.75% of dogs in veterinary practice. Treat...
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomize...
Background: The safety profile of anti-epileptic drugs (AEDs) is an important consideration for the ...
A significant number of cases of clinical canine epilepsy remain difficult to control in spite of th...
Eleven dogs diagnosed with refractory idiopathic epilepsy were treated orally with gabapentin for a ...
Abstract Background Imepitoin ...
Background: Various antiepileptic drugs (AEDs) are used for the management of canine idiopathic epil...
The purpose of this study was to evaluate the long-term (12 months) efficacy and tolerability of ime...
Background: Epilepsy is a chronic neurological condition characterised by recurrent epileptic seizur...
A one-year clinical trial was conducted to compare phenobarbital and potassium bromide (KBr) monothe...
Idiopathic Epilepsy (IE) in the dog is the major cause of epileptic seizures. Neoplasia, inflammator...
Abstract Background Behavioural changes associated with idiopathic epilepsy (IE) have been identifie...
In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over th...
In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over th...
Epilepsy is a common neurological disorder affecting 0.6–0.75% of dogs in veterinary practice. Treat...
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomize...
Background: The safety profile of anti-epileptic drugs (AEDs) is an important consideration for the ...
A significant number of cases of clinical canine epilepsy remain difficult to control in spite of th...
Eleven dogs diagnosed with refractory idiopathic epilepsy were treated orally with gabapentin for a ...